Absorption spectroscopy for the estimation of glycated hemoglobin (HbA1c) for the diagnosis and management of diabetes mellitus: A pilot study

Photomedicine and Laser Surgery

Volumn 31, Issue 5, 2013, Pages 219-224

  Mallya, Madhukar ^a   Shenoy, Revathi ^a   Kodyalamoole, Gopalkrishna ^a   Biswas, Monalisa ^a   Karumathil, Jisha ^a   Kamath, Sudha ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVES; CLINICAL BIOCHEMISTRY; DIRECT ABSORPTION SPECTROSCOPIES; GLYCATED HEMOGLOBIN (HBA1C); GLYCATED HEMOGLOBINS; SINGLE-BEAM SPECTROPHOTOMETER; SPECTROSCOPIC MEASUREMENTS; SPECTROSCOPIC METHOD;

ABSORPTION SPECTRA; ABSORPTION SPECTROSCOPY; AFFINITY CHROMATOGRAPHY; ASSAYS; BIOCHEMISTRY; ELECTROPHORESIS; ESTIMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION EXCHANGE; SPECTROSCOPIC ANALYSIS;

HEMOGLOBIN;

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD; DIABETES MELLITUS; HUMAN; MIDDLE AGED; PILOT STUDY; X RAY ABSORPTION SPECTROSCOPY;

ADULT; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MIDDLE AGED; PILOT PROJECTS; X-RAY ABSORPTION SPECTROSCOPY;

EID: 84880555878     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2012.3421     Document Type: Article

References (34)

1. World Health Organization (1999). Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, 2 ed. Geneva: World Health Organization.
2. American Diabetes Association Home page. Available at: http://www.diabetes.org
3. Flower, M.J. (2008). Microvascular and macrovascular complications of diabetes. Clin. Diabetes 26,77-82.
4. Shaw, J.E., Sicree, R.A., and Zimmet, P.J. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4-14.
5. Forsham, P.H. (1982). Diabetes mellitus: a rational plan for management. Postgrad. Med. 71, 139-154.
6. Hollander, P. (1984). The case for tight control in diabetes, Postgrad. Med.75, 80-87.
7. Saudek, C.D., Kalyani, R.R., and Derr, R.L. (2005). Assessment of glycemia in diabetes mellitus: hemoglobin A1c. J. Assoc. Physicians India 53, 299-305.
8. Jeffcoate, S.L. (2004). Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet. Med. 21, 657-665.
9. Bennett, C.M., Guo, M., and Dharmage, S.C. (2007). HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med. 24, 333-343.
10. Ikeda, N., Iijima, R., Hara, H., Moroi, M., Nakamura, M., Sugi, K. (2012).Glycated hemoglobin is associated with the complexity of coronary artery disease, even in non-diabetic adults. J. Atheroscler. Thromb. 19, 1066-1072.
11. Debard, A., Charmion, S., Ben, A.S., Gaultier, J.B., and Cathe bras, P.,(2009). Inappropriate low glycatedhemoglobin and hemolysis. Rev. Med. Interne 30, 525-527.
12. Youssef, D., El Abbassi, A., Jordan, R.M., and Peiris, A.N. (2008). Fructosamine-an underutilized tool in diabetes management: case report and literature review. Tenn. Med. 101, 31-33.
13. Paroni, R., Ceriotti, F., Galanello, R., Battista, L.G., Panico, A., Scurati, E., et al. (2007). Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma, Clin. Biochem. 40, 1398-1405.
14. Kohzuma, T., and Koga, M. (2010). Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus. Mol. Diagn. Ther. 14, 49-51.
15. Koga, M., and Kasayama, S. (2010). Clinical impact of glycated albumin as another glycemic control marker. Endocr J. 57, 751-762.
16. Matsuyama, T., Katayama, Y., and Fujita, S., (1995) Recent progress in evaluation of glycemic control by glycated protein and 1,5-AG]. Rinsho Byori. 43, 445-448.
17. Dungan, K.M., (2008).1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemicexcursions. Expert Rev. Mol. Diagn. 8, 9-19.
18. Yamakoshi, M., and Kawazu, S. (2008). Lucica MI urinary myoinositol kit: a new diagnostic test for diabetes mellitus and glucose intolerance. Mol. Diagn. Ther. 12, 189-191.
19. Schnedl, W.J., Leitner, G., and Lipp, R.W. (1997). Glycosylated hemoglobin and glycosylated proteins for metabolic control of diabetes mellitus [in German]. Wien Med. Wochenschr. 147, 359-361.
20. Chu, C.H., Lam, H.C., Lee, J.K., Wang, M.C., Lu, C.C., Sun C.C., et al. (2009). Common hemoglobin variants in southern Taiwan and their effect on the determination of HbA1c by ion-exchange high-performance liquid chromatography. J. Chin. Med. Assoc. 72, 362-367.
21. Tominaga, M., Makino, H., Yoshino, G., Kuwa, K., Takei, I., Aono Y, et al., (2005). Japanese standard reference material JDS Lot 2 for haemoglobin A1c. II: Present state of standardization of haemoglobin A1c in Japan using the new reference material in routine clinical assays, Ann. Clin. Biochem. 42, 47-50.
22. Castagnola, M., Caradonna, P., Bertollini, A., Cassiano, L., Rossetti D.V., and Salvi M.L.(1985). Determination of the non-enzymatic glycation of hemoglobin by isoelectrofocusing of its globin chains. Clin. Biochem. 18, 327-331.
23. Lahousen T., Roller, R.E., Lipp, R.W., and Schnedl, W.J. (2002) Determination of glycatedhemoglobins (HbA1c) [in German].Wien Klin. Wochenschr.114, 301-305
24. Li, Y., Jeppsson, J.O., Jorntén-Karlsson, M., Linné Larsson, E., Jungvid H., Galaev I.Y., et al. (2002).Application of shielding boronate affinity chromatography in the study of the glycation pattern of haemoglobin. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 776, 149-160.
25. Bhat, V.S., Dewan, K.K., and Krishnaswamy, P.R. (2011). Diagnostic dilemma of HbA1c detection in presence of a hemoglobinopathy: a case report. Indian J. Clin. Biochem. 26, 91-95.
26. Manley, S., John, W.G., and Marshall, S., (2004). Introduction of IFCC reference method for calibration of HbA: implications for clinical care. Diabet. Med. 21, 673-676.
27. Chawla, S., and Pundir, C.S. (2011). An electrochemical biosensor for fructosylvaline for glycosylated hemoglobin detection based on core-shell magnetic bionanoparticles modified gold electrode. Biosens. Bioelectron. 26, 3438-3443.
28. Chawla, S., and Pundir, C.S. (2012).Anamperometric HbA1(C) biosensor based on immobilization of fructosylaminoacid oxidase onto ZnO nanoparticles-polypyrrole film. Anal. Biochem. 430, 156-162.
29. Berger, A.J., Irving, I., and Feld, M.S., (1997). Feasibility of Measuring Blood Glucose Concentration by Near-infrared Raman Spectroscopy. Spectrochim. Acta A Mol. Biomol. Spectrosc. 53, 287-292.
30. Barman, I., Dingari, N.C., Kang, J.W., Horowitz, G.L., Dasari, R.R., and Feld, M.S. (2012). Raman spectroscopy-based sensitive and specific detection of glycated haemoglobin. Anal. Chem. 84, 2474-2482.
31. Berger, A.J. (1999). Laser technology for glucose monitoring. Diabetes Technol. Ther. 1, 121-128.
32. Upstone
33. Franz, X.S. (2001). Biological Macromolecules: UV-visible Spectrophotometry, Encyclopedia of Life Science /Macmillan Publishers Ltd, Nature Publishing Group. Available at: www.els.net
34. Carl, A.B., Edward, R. A., and David, E.B. (1972). Tietz text book of clinical chemistry and molecular diagnosis, 4th ed. St. Louis, MO: Elsevier Saunders.